VALERIE GOSS: Open Payments
NPI 1063939569 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,167 in 122 payments from 26 companies in 2025. Trend: 2023 $2,313 · 2024 $2,571 · 2025 $2,167
Food & beverage: $2,167
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $402 |
| Eisai Inc. | 27 | $322 |
| UCB, Inc. | 9 | $189 |
| Novartis Pharmaceuticals Corporation | 10 | $188 |
| CATALYST PHARMACEUTICALS, INC. | 4 | $103 |
| CSL Behring | 4 | $82 |
| TG Therapeutics, Inc. | 4 | $79 |
| Lundbeck LLC | 4 | $70 |
| Vanda Pharmaceuticals Inc. | 2 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
Products named: Leqembi, KESIMPTA, UBRELVY, Rystiggo, QULIPTA, VYALEV, FYCOMPA, REXULTI.
Industry payments across KY — which companies pay providers there.
